SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-19-011660
Filing Date
2019-06-27
Accepted
2019-06-27 17:00:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SCHEDULE 13G sc13g0619a3vivo_biopharm.htm SC 13G/A 51379
  Complete submission text file 0001213900-19-011660.txt   52883
Mailing Address 115 NICHOLSON LANE SAN JOSE CA 95134
Business Address 115 NICHOLSON LANE SAN JOSE CA 95134 650-889-5020
BioPharmX Corp (Subject) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: SC 13G/A | Act: 34 | File No.: 005-87755 | Film No.: 19926103
SIC: 2834 Pharmaceutical Preparations

Mailing Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301
Business Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301 650 688 0822
Vivo Capital VIII, LLC (Filed by) CIK: 0001618789 (see all company filings)

IRS No.: 471761992 | Fiscal Year End: 1231
Type: SC 13G/A